CKCarolyn Kuz

Carolyn Kuz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carolyn Kuz has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Worry and Anxiety in the Era of Early Diagnosis and Disease Modifying Treatment for Alzheimer’s Disease

    by Shana D. Stites, Katherine Lee, Carolyn Kuz, David Mandell, Hillary R. Bogner, Rebecca Brown

    Purpose of Review: Psychologists and psychiatrists are well-positioned to be at the forefront of addressing the challenges posed by anxiety in early diagnosis and treatment of Alzheimer’s disease (AD) dementia that are unfolding in primary care settings. The present article provides a summary of emerging areas in Alzheimer’s disease testing and research to guide clinical decisions and research pursuits. Recent Findings: The present article provides an overview of how anxiety is understood in early diagnosis of dementia due to AD, its influence in AD-related mechanisms, and the implications of these findings on current research practices. Summary: We conducted focused literature reviews between January and June 2026 and synthesized the information to provide a narrative review. Overall, the clinical roles of anxiety in AD dementia are expanding— from being viewed primarily as reactions to cognitive decline to serving as informative features of the diagnostic process and clinical course of the disease.

  • Open Access

    Four Common Beliefs About Patient Memory Evaluations: Who Has Them and What Modifies Them?

    by Shana D. Stites, Carolyn Kuz, Emily A. Largent, Kristin Harkins, Abba Krieger, Pamela Sankar, Sarah J. Barber

    Understanding public beliefs about patients at memory centers may inform efforts to promote early diagnosis and guide clinical discussions of Alzheimer’s disease (AD). Adults (N=3,527) read a vignette describing a fictional person at a memory center and rated the person’s condition as a mental illness, part of typical aging, and psychological or biological origins. Vignettes varied by AD biomarker result, symptom stage, and treatment availability. Participants most strongly believed that the condition was part of typical aging and biological in origin, though beliefs varied across subgroups. Black and Asian participants reported stronger beliefs than White participants that the condition was a mental illness ( β =0.39, P β =0.46, P β =0.19, P β =0.14, P P =0.04). Biomarker positivity heightened biological and lowered psychological attributions (all P <0.05). The findings offer specific insights to guide intervention.


  • Predictors of extreme future time perspective change in persons who learn an Alzheimer’s disease biomarker test result

    by Shana D. Stites, Mehek Dedhia, Carolyn Kuz

    Future time perspective (FTP) refers to a person’s perceptions of the future as either limited or open-ended (Carstensen, 2006; Carstensen et al., 1999; Lang & Carstensen, 2002). Individual differe...


  • Open Access

    Effects of caregiving experience on expectations of becoming an Alzheimer’s disease caregiver in the future

    by Shana D Stites, Carolyn Kuz, Kristin Harkins, Pamela Sankar, Norma B Coe, Mary Mittelman

    Objectives: Research often focuses on persons who are or have been caregivers to a person with dementia. Little is known about stigma reactions in persons who expect to care for a person with Alzheimer’s disease (AD). Understanding these beliefs may help guide clinical discussions with family members of persons with AD, particularly those diagnosed in the early stages. Methods: A sample of 3,527 adults was randomized to read a vignette describing a fictional person with either a positive or a negative AD biomarker test result. Bivariate and multivariable analyses examined associations between AD caregiver status (expected and experienced) and responses on a modified Family Stigma in Alzheimer’s Disease Scale (FS-ADS). Results: About 31% (n = 1,090) of participants expected to be a caregiver for a person with AD, and most (63%) had previously been a caregiver. Controlling for differences in caregiving experience and other potential confounders, participants expecting (vs. not) to be AD caregivers reported higher willingness to support, more pity, and fewer negative aesthetic attributions than participants with (vs. without) AD caregiving experience (all p < .05). Discussion: Caregiving experience is a strong predictor of a person’s expectations of becoming one in the future, which runs counter to observed caregiving patterns, suggesting that for most people, becoming a caregiver is unexpected. Helping individuals set more accurate expectations for future caregiving roles is essential to support planning and preparation. Specific findings may inform the content of support and education programs that could accompany disclosure of AD biomarkers and early diagnosis.

  • Open Access

    Public profiles in Alzheimer’s disease stigma: Unsupported, discriminated, and alone

    by Shana D. Stites, Carolyn Kuz, Kristin Harkins, Jonathan D. Rubright, Rebecca Johnson

    Introduction: Public stigma of Alzheimer’s disease (AD) can delay help-seeking and be a barrier to research participation. This study aimed to understand what, if any, patterns exist among aspects of AD stigma. Knowing this may advance opportunities to reduce AD stigma. Methods: Adult respondents ( N = 317) read a vignette about a man with mild stage AD dementia. Afterward, respondents answered the modified Family Stigma in Alzheimer’s Disease Scale (FS-ADS), which measures: Structural Discrimination, Negative Severity Attributions, Negative Aesthetic Attributions, Antipathy, Supportiveness, Pity , and Social Distance . In this correlational study, latent class analyses were used to derive response profiles. Regression models were used to assess correspondence of personal characteristics with profile membership. Results: Three profiles emerged from latent class analysis of four FS-ADS domains of: Structural Discrimination, Negative Severity Attributions, Supportiveness , and Social Distance. Two profiles characterized about 66.8% of respondents and were similar except for one distinguishing quality: beliefs that a person with AD would receive support from others. Additionally, membership in the “expecting higher support” profile was associated with identifying as White and having lower educational attainment, while membership in the “expecting lower support” profile was associated with relatively higher educational attainment. Conclusions: Beliefs about a lack of support, worries about discrimination, and expectations of social distance may depict a topic cluster to leverage in public messaging campaigns intended to reduce AD stigma. In doing so, our findings suggest it will be essential to consider the age and education level of the intended audience.

  • Are knowledge and interpersonal contact cures for Alzheimer’s stigma? Data from caregivers offer clues.

    by Shana D. Stites, Rosalie Schumann, Carolyn Kuz, Kristin Harkins, Emily Largent, Abba Krieger, Pamela Sankar, Megan Zuelsdorff

    Research on caregivers suggests interpersonal contact with persons with Alzheimer's disease (AD) and higher disease-oriented knowledge may heighten AD stigma, though these same mechanisms are often employed in anti-stigma campaigns. If we better understand associations among caregiver experience, interpersonal contact, AD knowledge and AD stigma, we can develop improved ways of reducing stigma and avoid unintended consequences. In a factorial design experiment, 2,371 participants read a vignette describing a fictional person; the vignette varied on clinical symptom stage, AD biomarker result, and treatment availability. Multivariable analyses assessed effects of caregiver experience, interpersonal contact, and different domains of disease-oriented knowledge on modified Family Stigma in Alzheimer's Disease Scale (FS-ADS) outcomes. Interaction analyses tested how clinical features may modify those associations. AD caregiver experience was associated with higher reactions on 6 of 7 FS-ADS domains. Disease-oriented knowledge, independent of content domain, did not substantially affect those associations. However, knowledge of caregiving, treatment, and life impact associated with lower FS-ADS scores, and knowledge about disease course and risk factors associated with higher reactions on FS-ADS domains. Knowledge of treatment modified reactions to symptoms and treatment availability. Knowledge of disease course modified reactions to a biomarker result. AD caregiver experience and interpersonal contact did not modify associations between clinical characteristics and FS-ADS domains. Distinct associations among different domains of AD knowledge and stigma outcomes should be considered when developing anti-stigma campaigns. Failure to do so risks worsening rather than alleviating AD stigma.